Risk of De Novo Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis Treated With IL‐17A Inhibitors: A Population‐Based Study. - Alsakarneh, Saqr; Al Ta'ani, Omar; Aburumman, Razan; Mikhail, Inas; Hashash, Jana G.; Farraye, Francis A. (Alimentary Pharmacology & Therapeutics, 2025)